ALLORION THERAPEUTICS

Allorion Therapeutics is a biotechnology company that focuses on creating new small molecule drugs for treating cancer and autoimmune diseases... Our goal is to pioneer the next generation of targeted therapies for cancer and autoimmune diseases. Our dedicated team of drug discovery and development experts is committed to creating novel small molecule drugs, distinguished by their unique mechanisms of action... Our strategy is twofold. First, we focus on developing mutant-selective and isoform-specific drugs that target well-known markers in non-conventional ways. This approach aims to enhance efficacy and combat drug resistance. Secondly, we leverage our innovative data and screening platforms to discover novel targets and chemicals, broadening the scope of precision medicine. The synergy of these approaches ensures a systematic and sustainable evolution of our pipeline, poised to transform the treatment paradigm in cancer and autoimmune diseases.

Primary location: Natick United States